Advertisement

Topics

Latest "irbesartan amlodipine irbesartan Hypertension" News Stories

08:42 EDT 20th October 2017 | BioPortfolio

Here are the most relevant search results for "irbesartan amlodipine irbesartan Hypertension" found in our extensive news archives from over 250 global news sources.

More Information about irbesartan amlodipine irbesartan Hypertension on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about irbesartan amlodipine irbesartan Hypertension for you to read. Along with our medical data and news we also list irbesartan amlodipine irbesartan Hypertension Clinical Trials, which are updated daily. BioPortfolio also has a large database of irbesartan amlodipine irbesartan Hypertension Companies for you to search.

Showing "irbesartan amlodipine irbesartan Hypertension" News Articles 1–25 of 814

Extremely Relevant

Global and Chinese Irbesartan Industry, 2017 Market Research Report [Report Updated: 21062017] Prices from USD $3000

The 'Global and Chinese Irbesartan Industry, 20122022 Market Research Report' is a professional and indepth study on the current state of the global Irbesartan industry with a focus on the Chinese market. The report provides key statistics on the market status of the Irbesartan manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry...


Global Irbesartan Market Research Report Forecast 20172022 [Report Updated: 05072017] Prices from USD $2800

Delivery of the Report will take 4872 hours once order is placed.The Global Irbesartan Market Research Report Forecast 20172022 is a valuable source of insightful data for business strategists. It provides the Irbesartan industry overview with growth analysis and historical futuristic cost, revenue, demand and supply data as applicable. The research analysts provide an elaborate description o...

Global Irbesartan Market Research Report Forecast 20172022 [Report Updated: 01072017] Prices from USD $2800

Delivery of the Report will take 4872 hours once order is placed.The Global Irbesartan Market Research Report Forecast 20172022 is a valuable source of insightful data for business strategists. It provides the Irbesartan industry overview with growth analysis and historical futuristic cost, revenue, demand and supply data as applicable. The research analysts provide an elaborate description of ...


Human medicines European public assessment report (EPAR): Aprovel, irbesartan, Revision: 36, Authorised

Human medicines European public assessment report (EPAR): Sabervel, irbesartan, Revision: 2, Withdrawn

Human medicines European public assessment report (EPAR): Karvea, irbesartan, Revision: 35, Authorised

Unisia Amlodipine + Candesartan Drug Insights, 2017 [Report Updated: 10072017] Prices from USD $1000

DelveInsight's pharmaceuticals report, Unisia Amlodipine + Candesartan Drug Insights, 2017 highlights the Drug marketed details and the Global API Manufacturers details across the globe along with the location. The report covers the Global Market Assessment of the Unisia Amlodipine + Candesartan covering the historical global sales and also provides the Unisia Amlodipine + Candesartan sales esti...

Simultaneous Determination of Amlodipine and Its Counterion Besylate

Thermo Fisher Scientific has developed a simple, rapid, reliable, and accurate high-performance liquid chromatography (HPLC) method for the simultaneous determination of amlodipine and besylate in an amlodipine besylate drug substance.

Unisia Amlodipine + Candesartan API Insights, 2017 [Report Updated: 10072017] Prices from USD $500

DelveInsight's, Unisia Amlodipine + Candesartan API Insights, 2017 report provides product and API manufacturers details across the globe along with the location. The report gives the clear idea on the country wise DMF filed by worldwide companies related to the Unisia Amlodipine + Candesartan. The report also highlights the patent details of Unisia Amlodipine + Candesartan. The report is built u...

Relevant

Metoprolol Increases Uric Acid, Risk of Gout

In a study of African Americans with hypertension-related CKD, metoprolol, but neither ramipril nor amlodipine, increased serum uric acid levels.

Global and Chinese Amlodipine Naphthoquinone Industry, 2017 Market Research Report [Report Updated: 21062017] Prices from USD $3000

The 'Global and Chinese Amlodipine Naphthoquinone Industry, 20122022 Market Research Report' is a professional and indepth study on the current state of the global Amlodipine Naphthoquinone industry with a focus on the Chinese market. The report provides key statistics on the market status of the Amlodipine Naphthoquinone manufacturers and is a valuable source of guidance and direction for compani...

Long-term Candesartan Linked to Less New Diabetes vs Amlodipine

While candesartan and amlodipine lower blood pressure and cardiovascular event rates equally, candesartan is associated with significantly reduced rates of new-onset diabetes in 10-year follow-up data. Medscape Medical News

MKSAP: 49-year-old man with a family history of type 2 diabetes mellitus

Test your medicine knowledge with the MKSAP challenge, in partnership with the American College of Physicians. A 49-year-old man seeks advice on ways to prevent the development of type 2 diabetes mellitus because of a strong family history (mother, sister, and brother) of the disease. History is significant for hypertension, for which he takes losartan and amlodipine […]

Global Amlodipine Besylater Market Research Report Forecast 2017 to 2022 [Report Updated: 29062017] Prices from USD $2800

Delivery of the Report will take 23 working days once order is placed.The Global Amlodipine Besylater Market Research Report Forecast 20172022 is a valuable source of insightful data for business strategists. It provides the Amlodipine Besylater industry overview with growth analysis and historical futuristic cost, revenue, demand and supply data as applicable. The research analysts provide an el...

Blood pressure better controlled with 'MAP' for doctors

A quality improvement program designed to better control hypertension in primary care practices notably improved hypertension control in six months, according to research presented today at the American Heart Association (AHA) Council on Hypertension, AHA Council on Kidney in Cardiovascular Disease, American Society of Hypertension Joint Scientific Sessions 2017, in San Francisco.

Early-Onset Hypertension Confers Greater Cardiovascular Risk than Late-Onset Hypertension (FREE)

Early-onset hypertension also is associated with excess hypertension risk in offspring.

Lifestyle and Progression From HDP to Chronic Hypertension

Can the risk of chronic hypertension after gestational hypertension or pre-eclampsia be significantly reduced by adherence to a beneficial lifestyle? The BMJ (formerly known as the British Medical Journal)

Hypertension during pregnancy may affect women's long-term cardiovascular health

(Wiley) Women who experience hypertension during pregnancy face an increased risk of heart disease and hypertension later in life, according to a new study.

[Comment] Stretching the carotid sinus to treat resistant hypertension

Around a quarter of adults have hypertension, and by 2025, the number affected might be more than 1·5 billion people worldwide.1 Despite important advances in pharmacotherapy in the past 40 years, resistant hypertension—that is, persistently raised ambulatory blood pressure despite treatment with at least three antihypertensive drugs, including a diuretic—occurs in about 13% of treated adults...

Community Health Workers May Help Control Hypertension

A program led by community health workers reduced systolic and diastolic BP and improved hypertension control among low-income, uninsured patients with hypertension vs usual clinician care. Medscape Medical News

Dimerix hosts US key opinion leader meeting with NephCure Kidney International focused on development path of DMX-200 in kidney disease

MELBOURNE, Australia, 6th June 2017: Dimerix Limited (ASX: DXB), a clinical-stage biotechnology company discovering and developing new therapeutic treatments identified using its proprietary assay technology said it has hosted a half-day meeting on Saturday 3 June 2017 in Baltimore, Maryland United States, with representatives from the patient advocacy group NephCure Kidney International and lea...

Tackling hypertension in India

The World Health Organization has chosen hypertension as the public health threat it will focus on for the next year. The problem is particularly pressing in India, and Anita Jain, the BMJ's India editor, spoke to François Decaillet, Coordinator for Health Programs, WHO India, about what needs to be done to tackle hypertension in the country's...

Gut bacteria metabolism may factor into hypertension

(University of Illinois College of Agricultural, Consumer and Environmental Sciences) One in three American adults suffers from high blood pressure, or hypertension. The disease can be passed down in families, and certain lifestyle factors such as smoking, high-sodium diets, and stress can increase the risk. In recent years, scientists have discovered that certain gut bacteria may contribute to hy...

Human medicines European public assessment report (EPAR): Twynsta, telmisartan / amlodipine, Revision: 8, Authorised

Dimerix announces DMX-200 tablet manufacture and human pharmacokinetic study timeline

MELBOURNE, Australia, 5th September 2017: Dimerix Limited (ASX: DXB), is pleased to announce that manufacturing has been scheduled for later this month to produce the extended release tablet of propagermanium which will be used in the Company’s DMX-200 human pharmacokinetic study and Phase 2b trial in Chronic Kidney Disease. DMX-200, Dimerix’s lead drug development program which s...


Quick Search
Advertisement
 

News Quicklinks